Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.49 |
| ▸ | MAPT | P10636 | 8/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.49 |
| ▸ | TP53 | P04637 | 7/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | HPGD | P15428 | 6/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.49 |
| ▸ | POLH | Q9Y253 | 6/20 | 0.49 |
| ▸ | XDH | P47989 | 6/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.49 |
| ▸ | DAPK1 | P53355 | 5/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3470609 | 0.81 | MEN1 (0.47) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL1133630 | 0.72 | MEN1 (0.45) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL30684642 | 0.72 | CYP3A4 (0.78) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL2565483 | 0.72 | CYP3A4 (0.78) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL4104591 | 0.69 | MEN1 (0.64) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL19934851 | 0.68 | KDM4E (0.51) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL19929827 | 0.68 | KDM4E (0.51) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL22142507 | 0.67 | MEN1 (0.61) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL12940979 | 0.67 | MEN1 (1.00) | MEN1KMT2AHSP90AA1CYP3A4KDM4E | |
| SCHEMBL5040391 | 0.67 | MEN1 (0.70) | MEN1KMT2AHSP90AA1CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| EP-4479145-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| EP-4479146-A1 | COSMETIC COMPOSITION | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| CN-119110720-A | Cosmetic composition | 布茨公司 | 2024-12-10 | — | — | CN | claimed |
| CN-116555284-B | Application of GmBBX4 gene in regulating and controlling soybean isoflavone synthesis | 南京农业大学 | 2023-12-29 | — | — | CN | claimed |
| WO-2023156069-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| WO-2023156070-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| CN-116555284-A | Application of GmBBX4 gene in regulating and controlling soybean isoflavone synthesis | 南京农业大学 | 2023-08-08 | — | — | CN | claimed |
| EP-1359215-B1 | Use of a soya cell strains with high isoflavone content | NESTLE SA (CH) | 2010-03-10 | — | — | EP | claimed |
| EP-1988891-A2 | COMPOSITIONS AND METHODS FOR INDUCING BONE GROWTH AND INHIBITING BONE LOSS | NESTEC S.A. (CH) | 2008-11-12 | — | — | EP | claimed |
| EP-1956923-A1 | ISOFLAVONE COMPOSITIONS FOR REDUCING ACCUMULATION OF BODY FAT IN MALE MAMMALS, AND METHODS FOR THEIR USE | NESTEC S.A. (CH) | 2008-08-20 | — | — | EP | claimed |
| WO-2007100671-A2 | COMPOSITIONS AND METHODS FOR INDUCING BONE GROWTH AND INHIBITING BONE LOSS | NESTEC S.A. (CH) | 2007-09-07 | — | — | WO | claimed |
| WO-2007051629-A1 | ISOFLAVONE COMPOSITIONS FOR REDUCING ACCUMULATION OF BODY FAT IN MALE MAMMALS, AND METHODS FOR THEIR USE | NESTEC S.A. (CH) | 2007-05-10 | — | — | WO | claimed |
| US-20050050589-A1 | Soya cell strains with high isoflavone content | NESTEC S.A. (CH) | 2005-03-03 | — | — | US | claimed |
| EP-1501919-A1 | SOYA CELL STRAINS WITH HIGH ISOFLAVONE CONTENT | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2005-02-02 | — | — | EP | claimed |
| WO-2003093456-A1 | SOYA CELL STRAINS WITH HIGH ISOFLAVONE CONTENT | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2003-11-13 | — | — | WO | claimed |
| EP-1359215-A1 | Soya cell strains with high isoflavone content | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2003-11-05 | — | — | EP | claimed |
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| US-6171638-B1 | Production of isoflavone enriched fractions from soy protein extracts | ARCHER DANIELS MIDLAND COMPANY | 2001-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | SGMS2, SGMS1, CERS2 | MEN1 2323/4885KMT2A 3447/4885HSP90AA1 4007/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | MEN1 2548/4885KMT2A 3132/4885HSP90AA1 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.